178 related articles for article (PubMed ID: 22211316)
1. Iron replacement therapy in the routine management of blood donors.
Bryant BJ; Yau YY; Arceo SM; Daniel-Johnson J; Hopkins JA; Leitman SF
Transfusion; 2012 Jul; 52(7):1566-75. PubMed ID: 22211316
[TBL] [Abstract][Full Text] [Related]
2. Ascertainment of iron deficiency and depletion in blood donors through screening questions for pica and restless legs syndrome.
Bryant BJ; Yau YY; Arceo SM; Hopkins JA; Leitman SF
Transfusion; 2013 Aug; 53(8):1637-44. PubMed ID: 23305102
[TBL] [Abstract][Full Text] [Related]
3. The effect of iron balance on platelet counts in blood donors.
Eder AF; Yau YY; West K
Transfusion; 2017 Feb; 57(2):304-312. PubMed ID: 27900761
[TBL] [Abstract][Full Text] [Related]
4. High-dose intravenously administered iron versus orally administered iron in blood donors with iron deficiency: study protocol for a randomised, controlled trial.
Macher S; Drexler C; Lindenau I; Sareban N; Schlenke P; Amrein K
Trials; 2016 Oct; 17(1):527. PubMed ID: 27793204
[TBL] [Abstract][Full Text] [Related]
5. Intravenous iron sucrose complex in the treatment of iron deficiency anemia during pregnancy.
al-Momen AK; al-Meshari A; al-Nuaim L; Saddique A; Abotalib Z; Khashogji T; Abbas M
Eur J Obstet Gynecol Reprod Biol; 1996 Nov; 69(2):121-4. PubMed ID: 8902444
[TBL] [Abstract][Full Text] [Related]
6. Goserelin acetate 10.8 mg plus iron versus iron monotherapy prior to surgery in premenopausal women with iron-deficiency anemia due to uterine leiomyomas: results from a Phase III, randomized, multicenter, double-blind, controlled trial.
Muneyyirci-Delale O; Richard-Davis G; Morris T; Armstrong J
Clin Ther; 2007 Aug; 29(8):1682-91. PubMed ID: 17919549
[TBL] [Abstract][Full Text] [Related]
7. A comparison between intravenous iron polymaltose complex (Ferrum Hausmann) and oral ferrous fumarate in the treatment of iron deficiency anaemia in pregnancy.
Singh K; Fong YF; Kuperan P
Eur J Haematol; 1998 Feb; 60(2):119-24. PubMed ID: 9508353
[TBL] [Abstract][Full Text] [Related]
8. A prospective randomized, controlled trial of intravenous versus oral iron for moderate iron deficiency anaemia of pregnancy.
Khalafallah A; Dennis A; Bates J; Bates G; Robertson IK; Smith L; Ball MJ; Seaton D; Brain T; Rasko JE
J Intern Med; 2010 Sep; 268(3):286-95. PubMed ID: 20546462
[TBL] [Abstract][Full Text] [Related]
9. Oral ferrous sulfate does not increase preoperative hemoglobin in patients scheduled for hip or knee arthroplasty.
Lachance K; Savoie M; Bernard M; Rochon S; Fafard J; Robitaille R; Vendittoli PA; Lévesque S; de Denus S
Ann Pharmacother; 2011 Jun; 45(6):764-70. PubMed ID: 21666087
[TBL] [Abstract][Full Text] [Related]
10. Iron status in 268 Danish women aged 18-30 years: influence of menstruation, contraceptive method, and iron supplementation.
Milman N; Clausen J; Byg KE
Ann Hematol; 1998; 77(1-2):13-9. PubMed ID: 9760147
[TBL] [Abstract][Full Text] [Related]
11. High-dose intravenous versus oral iron in blood donors with iron deficiency: The IronWoMan randomized, controlled clinical trial.
Drexler C; Macher S; Lindenau I; Holter M; Moritz M; Stojakovic T; Pieber TR; Schlenke P; Amrein K
Clin Nutr; 2020 Mar; 39(3):737-745. PubMed ID: 30981629
[TBL] [Abstract][Full Text] [Related]
12. [Effectiveness and tolerability of oral liquid ferrous gluconate in iron-deficiency anemia in pregnancy and in the immediate post-partum period: comparison with other liquid or solid formulations containing bivalent or trivalent iron].
Casparis D; Del Carlo P; Branconi F; Grossi A; Merante D; Gafforio L
Minerva Ginecol; 1996 Nov; 48(11):511-8. PubMed ID: 9005381
[TBL] [Abstract][Full Text] [Related]
13. Compensating for iron loss in regular blood donors using ferrous gluconate and ascorbic acid.
Radtke H; Tegtmeier J; Röcker L; Salama A; Kiesewetter H
Transfusion; 2005 Jul; 45(7):1236-7. PubMed ID: 15987376
[No Abstract] [Full Text] [Related]
14. Oral iron supplementation after blood donation: a randomized clinical trial.
Kiss JE; Brambilla D; Glynn SA; Mast AE; Spencer BR; Stone M; Kleinman SH; Cable RG;
JAMA; 2015 Feb; 313(6):575-83. PubMed ID: 25668261
[TBL] [Abstract][Full Text] [Related]
15. Maintenance of elevated versus physiological iron indices in non-anaemic patients with chronic kidney disease: a randomized controlled trial.
McMahon LP; Kent AB; Kerr PG; Healy H; Irish AB; Cooper B; Kark A; Roger SD
Nephrol Dial Transplant; 2010 Mar; 25(3):920-6. PubMed ID: 19906658
[TBL] [Abstract][Full Text] [Related]
16. The impact of iron supplementation efficiency in female blood donors with a decreased ferritin level and no anaemia. Rationale and design of a randomised controlled trial: a study protocol.
Pedrazzini B; Waldvogel S; Cornuz J; Vaucher P; Bize R; Tissot JD; Pecoud A; Favrat B
Trials; 2009 Jan; 10():4. PubMed ID: 19149890
[TBL] [Abstract][Full Text] [Related]
17. Large-dose intravenous ferric carboxymaltose injection for iron deficiency anemia in heavy uterine bleeding: a randomized, controlled trial.
Van Wyck DB; Mangione A; Morrison J; Hadley PE; Jehle JA; Goodnough LT
Transfusion; 2009 Dec; 49(12):2719-28. PubMed ID: 19682342
[TBL] [Abstract][Full Text] [Related]
18. Iron polymaltose versus ferrous gluconate in the prevention of iron deficiency anemia of infancy.
Jaber L; Rigler S; Taya A; Tebi F; Baloum M; Yaniv I; Haj Yehia M; Tamary H
J Pediatr Hematol Oncol; 2010 Nov; 32(8):585-8. PubMed ID: 20930652
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the Therapeutic Effects and Side Effects of Oral Iron Supplements in Iron Deficiency Anemia.
Wu TW; Tsai FP
Drug Res (Stuttg); 2016 May; 66(5):257-61. PubMed ID: 26697889
[TBL] [Abstract][Full Text] [Related]
20. Switching iron-deficient whole blood donors to plateletpheresis.
O'Meara A; Infanti L; Sigle J; Stern M; Buser A
Transfusion; 2012 Oct; 52(10):2183-8. PubMed ID: 22404849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
